March 29th 2024
Different clinical specialists in the management of inflammatory diseases discuss the role of adalimumab biosimilars in the treatment of their patients.
October 23rd 2023
Experts discuss the transition from biologics to biosimilars and emphasize the importance of adaptability when non-medical switching occurs.
May 29th 2020
January 10th 2019
January 24th 2018
October 30th 2017
August 23rd 2017
June 17th 2017
